| |
| |
|
| Insider
Information: |
Prokupets Elena |
| Relationship: |
Director |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
503,126 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
503,126 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
C4 Therapeutics, Inc. |
CCCC |
Director |
2020-10-06 |
0 |
2021-09-27 |
503,126 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-27 |
4 |
AS |
$50.04 |
$92,573 |
I/I |
(1,850) |
503,126 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-24 |
4 |
AS |
$50.10 |
$151,065 |
I/I |
(3,015) |
504,437 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-23 |
4 |
AS |
$50.35 |
$966,772 |
I/I |
(19,180) |
506,552 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-22 |
4 |
AS |
$50.09 |
$528,415 |
I/I |
(10,548) |
519,360 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-21 |
4 |
AS |
$50.13 |
$517,461 |
I/I |
(10,321) |
526,364 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-17 |
4 |
AS |
$50.04 |
$542,495 |
I/I |
(10,840) |
531,697 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-16 |
4 |
AS |
$48.62 |
$1,289,285 |
I/I |
(26,499) |
510,385 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-15 |
4 |
AS |
$48.71 |
$2,645,894 |
I/I |
(54,193) |
563,538 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-14 |
4 |
AS |
$50.01 |
$49,217 |
I/I |
(984) |
587,731 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-13 |
4 |
AS |
$50.07 |
$333,474 |
I/I |
(6,660) |
588,223 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-09-10 |
4 |
AS |
$50.00 |
$127,511 |
I/I |
(2,550) |
591,553 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-08-03 |
4 |
AS |
$45.16 |
$650,587 |
I/I |
(14,407) |
88,574 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-08-02 |
4 |
AS |
$45.01 |
$191,606 |
I/I |
(4,257) |
102,981 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-07-29 |
4 |
AS |
$45.00 |
$510,168 |
I/I |
(11,336) |
107,238 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
711,447 |
592,873 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
